GzB-IL18-armored 2G-T CAR T cells achieved greater tumor re-stimulation capacity (Figure S7D) accompanied by enhanced IFN-γ production (Figure S7E) and a trend toward increased CAR T cell expansion (Figure S7F) upon repeated tumor cell exposure. This evidence concerns the gene IL18 and neoplasm.